| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.023 | 0.4 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.4 |